1	Positive	positive	_	_	_	_	_	_	_
2	and	and	_	_	_	_	_	_	_
3	negative	negative	_	_	_	_	_	_	_
4	regulation	regulation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	granulocyte-macrophage	granulocyte-macrophage	_	_	_	_	_	_	_
7	colony-stimulating	colony-stimulating	_	_	_	_	_	_	_
8	factor	factor	_	_	_	_	_	_	_
9	promoter	promoter	_	_	_	_	_	_	_
10	activity	activity	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	AML1-related	aml1-related	_	_	_	_	_	_	_
13	transcription	transcription	_	_	_	_	_	_	_
14	factor	factor	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	PEBP2	PEBP2	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	granulocyte-macrophage	granulocyte-macrophage	_	_	_	_	_	_	_
3	colony-stimulating	colony-stimulating	_	_	_	_	_	_	_
4	factor	factor	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	GM-CSF	GM-CSF	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	gene	gene	_	_	_	_	_	_	_
9	promoter	promoter	_	_	_	_	_	_	_
10	contains	contain	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	consensus	consensus	_	_	_	_	_	_	_
13	sequence	sequence	_	_	_	_	_	_	_
14	for	for	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	polyomavirus	polyomavirus	_	_	_	_	_	_	_
17	enhancer	enhancer	_	_	_	_	_	_	_
18	binding-protein	binding-protein	_	_	_	_	_	_	_
19	2	2	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	PEBP2	pebp2	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	transcription	transcription	_	_	_	_	_	_	_
24	factor	factor	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	which	which	_	_	_	_	_	_	_
27	consists	consist	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	alpha	alpha	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	beta	beta	_	_	_	_	_	_	_
32	subunits	subunit	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	There	there	_	_	_	_	_	_	_
2	are	be	_	_	_	_	_	_	_
3	at	at	_	_	_	_	_	_	_
4	least	least	_	_	_	_	_	_	_
5	two	two	_	_	_	_	_	_	_
6	genes	gene	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	alpha	alpha	_	_	_	_	_	_	_
9	A	a	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	alpha	alpha	_	_	_	_	_	_	_
12	B	b	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	encoding	encode	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	alpha	alpha	_	_	_	_	_	_	_
17	subunit.	subunit.	_	_	_	_	_	_	_
18	alpha	alpha	_	_	_	_	_	_	_
19	B	B	_	_	_	_	_	_	_
20	is	be	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	mouse	mouse	_	_	_	_	_	_	_
23	homologue	homologue	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	human	human	_	_	_	_	_	_	_
26	AML1	aml1	_	_	_	_	_	_	_
27	gene	gene	_	_	_	_	_	_	_
28	detected	detect	_	_	_	_	_	_	_
29	at	at	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	breakpoints	breakpoint	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	t(8;21)	t(8;21)	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	t(3;21)	t(3;21)	_	_	_	_	_	_	_
36	myeloid	myeloid	_	_	_	_	_	_	_
37	leukemias	leukemia	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	examined	examine	_	_	_	_	_	_	_
3	alpha	alpha	_	_	_	_	_	_	_
4	A1	a1	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	an	an	_	_	_	_	_	_	_
7	alpha	alpha	_	_	_	_	_	_	_
8	A-gene	a-gene	_	_	_	_	_	_	_
9	product	product	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	alpha	alpha	_	_	_	_	_	_	_
13	B1	b1	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	alpha	alpha	_	_	_	_	_	_	_
16	B2	b2	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	two	two	_	_	_	_	_	_	_
19	alpha	alpha	_	_	_	_	_	_	_
20	B-encoded	b-encoded	_	_	_	_	_	_	_
21	isomers	isomer	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	for	for	_	_	_	_	_	_	_
24	their	their	_	_	_	_	_	_	_
25	effects	effect	_	_	_	_	_	_	_
26	on	on	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	GM-CSF	GM-CSF	_	_	_	_	_	_	_
29	promoter	promoter	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	PEBP2	pebp2	_	_	_	_	_	_	_
2	alpha	alpha	_	_	_	_	_	_	_
3	A1	a1	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	alpha	alpha	_	_	_	_	_	_	_
6	B1	b1	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	alpha	alpha	_	_	_	_	_	_	_
10	B2	b2	_	_	_	_	_	_	_
11	proteins	protein	_	_	_	_	_	_	_
12	bound	bind	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	PEBP2	pebp2	_	_	_	_	_	_	_
15	site	site	_	_	_	_	_	_	_
16	within	within	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	mouse	mouse	_	_	_	_	_	_	_
19	GM-CSF	GM-CSF	_	_	_	_	_	_	_
20	promoter	promoter	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	PEBP2	pebp2	_	_	_	_	_	_	_
2	alpha	alpha	_	_	_	_	_	_	_
3	A1	a1	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	alpha	alpha	_	_	_	_	_	_	_
6	B1	b1	_	_	_	_	_	_	_
7	enhanced	enhance	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	expression	expression	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	GM-CSF	GM-CSF	_	_	_	_	_	_	_
13	promoter-driven	promoter-driven	_	_	_	_	_	_	_
14	reporter	reporter	_	_	_	_	_	_	_
15	plasmid	plasmid	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	unstimulated	unstimulated	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	12-O-tetradecanoylphorbol	12-o-tetradecanoylphorbol	_	_	_	_	_	_	_
20	13-acetate/phytohemagglutinin-stimulated	13-acetate/phytohemagglutinin-stimulated	_	_	_	_	_	_	_
21	human	human	_	_	_	_	_	_	_
22	Jurkat	Jurkat	_	_	_	_	_	_	_
23	T	t	_	_	_	_	_	_	_
24	cells	cell	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	promoter	promoter	_	_	_	_	_	_	_
6	activity	activity	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	suppressed	suppress	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	alpha	alpha	_	_	_	_	_	_	_
11	B2	b2	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Coexpression	coexpression	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	alpha	alpha	_	_	_	_	_	_	_
4	B1	b1	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	alpha	alpha	_	_	_	_	_	_	_
7	B2	b2	_	_	_	_	_	_	_
8	showed	show	_	_	_	_	_	_	_
9	that	that	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	promoter	promoter	_	_	_	_	_	_	_
12	activity	activity	_	_	_	_	_	_	_
13	could	could	_	_	_	_	_	_	_
14	be	be	_	_	_	_	_	_	_
15	determined	determine	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	alpha	alpha	_	_	_	_	_	_	_
19	B1/alpha	B1/alpha	_	_	_	_	_	_	_
20	B2	b2	_	_	_	_	_	_	_
21	ratio	ratio	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Jurkat	Jurkat	_	_	_	_	_	_	_
2	cell	cell	_	_	_	_	_	_	_
3	extract	extract	_	_	_	_	_	_	_
4	contained	contain	_	_	_	_	_	_	_
5	PEBP2	pebp2	_	_	_	_	_	_	_
6	site-binding	site-binding	_	_	_	_	_	_	_
7	protein(s)	protein(s)	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	cross-reacted	cross-reacte	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	antimouse	antimouse	_	_	_	_	_	_	_
12	alpha	alpha	_	_	_	_	_	_	_
13	A1	a1	_	_	_	_	_	_	_
14	antibodies	antibody	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Northern	Northern	_	_	_	_	_	_	_
2	blot	blot	_	_	_	_	_	_	_
3	analysis	analysis	_	_	_	_	_	_	_
4	indicated	indicate	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	PEBP2	pebp2	_	_	_	_	_	_	_
10	alpha	alpha	_	_	_	_	_	_	_
11	A	A	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	alpha	alpha	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	AML1	AML1	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	beta	beta	_	_	_	_	_	_	_
21	genes	gene	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	Jurkat	Jurkat	_	_	_	_	_	_	_
24	cells	cell	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	further	further	_	_	_	_	_	_	_
3	studies	study	_	_	_	_	_	_	_
4	are	be	_	_	_	_	_	_	_
5	required	require	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	determine	determine	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	precise	precise	_	_	_	_	_	_	_
10	role	role	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	PEBP2	pebp2	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	GM-CSF	GM-CSF	_	_	_	_	_	_	_
16	promoter	promoter	_	_	_	_	_	_	_
17	activity	activity	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	present	present	_	_	_	_	_	_	_
21	findings	finding	_	_	_	_	_	_	_
22	suggested	suggest	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	importance	importance	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	relative	relative	_	_	_	_	_	_	_
28	ratio	ratio	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	different	different	_	_	_	_	_	_	_
31	PEBP2	pebp2	_	_	_	_	_	_	_
32	isoforms	isoform	_	_	_	_	_	_	_
33	in	in	_	_	_	_	_	_	_
34	regulating	regulate	_	_	_	_	_	_	_
35	the	the	_	_	_	_	_	_	_
36	levels	level	_	_	_	_	_	_	_
37	of	of	_	_	_	_	_	_	_
38	the	the	_	_	_	_	_	_	_
39	promoter	promoter	_	_	_	_	_	_	_
40	activity	activity	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

